Apoptosis: implications of basic research for clinical oncology
- 1 January 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (1) , 33-42
- https://doi.org/10.1016/s1470-2045(00)00193-5
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activationOncogene, 2000
- Apoptosis in Human Disease: A New Skin for the Old Ceremony?Biochemical and Biophysical Research Communications, 1999
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosisCell Death & Differentiation, 1998
- Mitochondria and ApoptosisScience, 1998
- The caspase family of cysteine proteasesBritish Medical Bulletin, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995
- Two TNF receptorsImmunology Today, 1992
- Involvement of the bcl -2 Gene in Human Follicular LymphomaScience, 1985